Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

9

Funds

1

About Grey Sky Venture Partners

Grey Sky Venture Partners is a seed fund focused on investing and supporting IP-based medtech start-ups.

Grey Sky Venture Partners Headquarter Location

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Grey Sky Venture Partners News

Inflammatix Raises $32M in Series C Funding

Jan 13, 2020

Inflammatix , a Burlingame, Calif.-based molecular diagnostics company delivering precision medicine at the point of care, raised $32m in Series C financing. The round included participation from existing investors Khosla Ventures, Northpond Ventures and Think.Health Ventures, and new investors including Grey Sky Venture Partners. The company intends to use the funds to advance its rapid HostDx™ tests through commercial launch in Europe and submission to the United States Food and Drug Administration in 2021. Led by Tim Sweeney, M.D., Ph.D., cofounder and chief executive officer, Inflammatix is a molecular diagnostics company that is reimagining diagnostics by “reading” the patient’s immune system to deliver rapid results that improve care and reduce major public health burdens. The company’s initial focus is on acute infection and sepsis, where its HostDx™ tests combine proprietary biomarkers and advanced machine learning to help physicians quickly get the right treatments to the right patients. Each test will be developed to run on the company’s sample-to-answer isothermal instrument platform in under 30 minutes, enabling the power of precision medicine at the point of care. FinSMEs

Grey Sky Venture Partners Investments

9 Investments

Grey Sky Venture Partners has made 9 investments. Their latest investment was in Inflammatix as part of their Series C on January 1, 2020.

CBI Logo

Grey Sky Venture Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/10/2020

Series C

Inflammatix

$32M

Yes

9

11/18/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

5/30/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

1/14/2019

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

12/20/2018

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/10/2020

11/18/2019

5/30/2019

1/14/2019

12/20/2018

Round

Series C

Series A

Series A

Seed VC

Series B

Company

Inflammatix

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$32M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

9

10

10

10

10

Grey Sky Venture Partners Fund History

1 Fund History

Grey Sky Venture Partners has 1 fund, including Gearbox.

Closing Date

Fund

Fund Type

Status

Amount

Sources

3/17/2016

Gearbox

$2.44M

1

Closing Date

3/17/2016

Fund

Gearbox

Fund Type

Status

Amount

$2.44M

Sources

1

Grey Sky Venture Partners Team

1 Team Member

Grey Sky Venture Partners has 1 team member, including current Founding Partner, Michael A. Banks.

Name

Work History

Title

Status

Michael A. Banks

The D. E. Shaw Group, Palisades Growth Capital, Steamboat Ventures, Intel, and Cornerstone Research Group

Founding Partner

Current

Name

Michael A. Banks

Work History

The D. E. Shaw Group, Palisades Growth Capital, Steamboat Ventures, Intel, and Cornerstone Research Group

Title

Founding Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.